One thing to know is that another drug called Zepbound contains the same active ingredient as Mounjaro — tirzepatide — and is FDA-approved for weight loss. Mounjaro is prescribed for those ...
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Courtesy of Mike Sabellico A spokesperson for Lilly, the US company that makes Mounjaro, as well as the similar Zepbound, said patient safety is a “top priority” and they “actively engage in ...
Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...